ESPEROVAX

Serial Number 98324183
731

Registration Progress

Application Filed
Dec 20, 2023
Under Examination
Jan 7, 2025
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 07, 2026 162 days

Trademark Image

ESPEROVAX

Basic Information

Serial Number
98324183
Filing Date
December 20, 2023
Published for Opposition
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Jan 6, 2026
Application
Pending
Classes
005 042

Rights Holder

Esperovax, Inc.

03
Address
46701 Commerce Center Dr.
Plymouth, MI 48170

Ownership History

Esperovax, Inc.

Original Applicant
03
Plymouth, MI

Esperovax, Inc.

Owner at Publication
03
Plymouth, MI

Legal Representation

Attorney
J. Matthew Buchanan

USPTO Deadlines

Next Deadline
162 days remaining
NOA E-Mailed - SOU Required
Due Date
July 07, 2026
Extension Available
Until January 07, 2027

Application History

32 events
Date Code Type Description Documents
Jan 7, 2026 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 6, 2026 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 6, 2026 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 6, 2026 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 30, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 30, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 6, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 28, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 11, 2025 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Aug 11, 2025 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Aug 11, 2025 PETG O PETITION TO REVIVE-GRANTED Loading...
Aug 11, 2025 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Aug 11, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 11, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 7, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 30, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 30, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 30, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 30, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 30, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 23, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 23, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 23, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 23, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 23, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 23, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 22, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 1, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Vaccines; Oral vaccines; Modified cells for medical or clinical use; yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases
Class 042
Medical research in the field of vaccines and medicines; Research and development of vaccines and medicines; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of vaccines and medicines; Pharmaceutical research and development; Research and development in the field of immunology; Research and development in the field of microorganisms, namely, research and development related to yeast; Research and development in the field of therapeutics; Development of pharmaceutical preparations and medicines; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products; Medical and scientific research; Research and development of pharmaceutical and therapeutic preparations; Pharmaceutical, biologic, and vaccine research and development

Classification

International Classes
005 042